title: Parkinson disease: Pimavanserin could be useful for treating psychosis in Parkinson disease.
authors.forename: Katie
authors.initials: K
authors.lastname: Kingwell
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000523:psychology*; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D058826:Serotonin 5-HT2 Receptor Agonists / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives*
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D010880:Piperidines; D058826:Serotonin 5-HT2 Receptor Agonists; D014508:Urea